Search fresh public links, source activity, and post angles for Emerging Therapy.
Fresh curated links around Emerging Therapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The therapy is part of a plan to develop gene therapies that can be efficiently delivered at lower doses, enabling them to be used against more than just “ultra-rare” conditions.
An immunotherapy typically used in advanced stages of multiple myeloma may be effective against an early form of the disease known as smoldering myeloma—offering a potential new op...
Discover how Cognition Therapeutics is redefining hope for Alzheimer’s and Dementia with Lewy bodies [JG1] with innovative, accessible therapies.
Exosome therapy has emerged as a solution to deliver treatments safely and effectively, and as a new approach to regenerative medicine. The post Extracellular vesicles: a growing...
While early, the findings suggest the therapy could be superior to Novartis’ Vijoice at treating “vascular anomalies,” a cluster of chronic conditions with few available treatments...
Travis Smith was a very serious baby. Born completely unable to hear, his mother, Sierra, struggled to see his personality shine through his mute world.
In recent years, interest in advanced wellness treatments has expanded beyond traditional supplements and lifestyle changes. One of the most talked-about therapies in regenerative...
If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
No medicines have been approved for stiff person syndrome yet. However, Kyverna Therapeutics' CAR-T cell therapy is headed towards approval. The post CAR-T therapy for stiff perso...
Pierre Fabre claims to now be “aligned” with U.S. regulators on the path forward for a twice-rejected treatment. Elsewhere, Argenx swapped CEOs and Blackstone made a $250 million b...
A groundbreaking advance in the treatment of acute myeloid leukemia (AML) heralds a new era in immunotherapy, addressing a long-standing challenge of targeting cancer cells without...
As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients. The post Top 10 Best Selling Gene Therapies...
In a groundbreaking stride against one of oncology’s most formidable challenges, researchers have unveiled promising clinical trial results exploring novel immunotherapeutic strate...
_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480.jpg)
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematologic malignancies, offering durable responses for patients with otherwise refractory dis...
A pioneering advancement in the treatment of advanced liver disease has emerged from the University of Edinburgh, offering fresh hope to patients who face dire prognoses due to cir...
Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and several targeted medicines for lung tumors.
There are no FDA-approved therapies for GPC3, a protein highly expressed by liver cancers. Oricell Therapeutics claims its cell therapy could be best in this class, but it faces co...
There are moments in medicine where something shifts. Not gradually. Not subtly. But […]
A phase 3 trial of Intellia Therapeutics’ in vivo gene editing therapy lonvoguran ziclumeran has hit its primary endpoint, leading the biotech to start a rolling submission for FDA...
Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.”After compelling data from a late-stage trial are prese...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.